Pain Management Devices

Pain Management Devices Market Outlook

The global pain management devices market was valued at approximately USD 6.35 billion in 2022, with an expected compound annual growth rate (CAGR) of around 10.8% from 2025 to 2035. This substantial growth can be attributed to an increasing prevalence of chronic pain conditions, an aging population, and rising awareness regarding effective pain management therapies. The growing adoption of minimally invasive surgical techniques is further propelling the demand for advanced pain management devices. Additionally, technological advancements and innovation in device design and efficacy have enhanced patient outcomes, thus fostering market growth. The increasing investment by healthcare providers in pain management infrastructure is expected to create lucrative opportunities for market players in the coming years.

Growth Factor of the Market

The pain management devices market is significantly driven by the rising incidence of chronic illnesses and pain-related disorders across the globe. Conditions such as arthritis, cancer, and neuropathic pain require effective management strategies, thus propelling the demand for advanced pain management devices. Furthermore, the increasing geriatric population, which is more susceptible to chronic pain due to age-related ailments, significantly contributes to the market growth. The growing emphasis on patient-centric care and quality improvement in healthcare settings has also encouraged the adoption of advanced pain management solutions. Additionally, developments in telehealth and remote patient monitoring technologies facilitate easier access to pain management therapies, thus expanding the market reach and improving patient compliance.

Key Highlights of the Market

• The market is projected to witness significant growth due to increased prevalence of chronic pain conditions.
• Technological advancements have led to the development of innovative pain management devices.
• Minimally invasive procedures are becoming the preferred choice among healthcare providers.
• Rising healthcare expenditure is anticipated to boost the demand for pain management solutions.
• The increasing adoption of telehealth services is enhancing patient access to pain management therapies.

By Product Type

Electrical Stimulation Devices:

Electrical stimulation devices are widely used in pain management due to their non-invasive nature and efficacy in alleviating pain symptoms. These devices work by delivering electrical impulses to specific nerves, which can interrupt pain signals sent to the brain. Transcutaneous electrical nerve stimulation (TENS) units are one of the most recognized forms of electrical stimulation devices, popular among patients seeking at-home pain management solutions. The increasing number of individuals opting for non-pharmacological pain relief methods is significantly driving the demand for these devices. Additionally, advancements in technology, such as smart electrical stimulation devices equipped with app connectivity, are expected to further enhance their popularity.

Radiofrequency Ablation Devices:

Radiofrequency ablation devices are utilized for targeted pain relief through the application of heat generated from radio waves to specific nerves. This method disrupts the nerve’s ability to transmit pain signals to the brain, providing significant relief for patients with chronic pain conditions. The growing prevalence of conditions like arthritis and joint pain is a major driver for the radiofrequency ablation device market. These procedures are known for their minimally invasive nature and shorter recovery times, making them increasingly popular among both patients and healthcare providers. Moreover, continuous advancements in radiofrequency technology have made these devices more effective and safer, further propelling market growth.

Analgesic Infusion Pumps:

Analgesic infusion pumps are advanced devices used to deliver medication continuously or intermittently to manage pain effectively. These pumps can provide tailored pain management solutions for patients undergoing surgical procedures or those experiencing chronic pain. With features like programmable dosing and patient-controlled analgesia, these devices enhance patient comfort and satisfaction. The increasing demand for personalized pain management approaches and the rising number of surgeries performed globally are driving the growth of this segment. Additionally, technological advancements in infusion pump systems, including wireless connectivity and remote monitoring options, are enhancing their effectiveness and adherence rates among patients.

Neurostimulation Devices:

Neurostimulation devices, including spinal cord stimulators and peripheral nerve stimulators, are utilized for managing chronic pain by altering pain signaling pathways. These devices work by delivering electrical impulses to the spinal cord or peripheral nerves, helping to alleviate pain sensations. Their effectiveness in treating conditions like neuropathic pain and complex regional pain syndrome has resulted in a growing adoption among healthcare professionals. The increasing focus on pain management in chronic conditions and advancements in neurostimulation technology, including rechargeable devices and wireless settings, are expected to drive this market segment. As the understanding of pain mechanisms continues to evolve, neurostimulation devices are anticipated to gain wider acceptance.

Acupuncture Devices:

Acupuncture devices are gaining traction as a non-invasive and holistic approach to pain management. These devices aid in performing acupuncture techniques that stimulate specific points on the body to relieve pain and promote healing. The rise in the popularity of alternative therapies and the increasing acceptance of acupuncture in mainstream healthcare have contributed to the growth of this segment. Moreover, the advancement in acupuncture devices, such as electronic acupuncture stimulators, has improved their effectiveness and ease of use. As more patients seek integrative pain management solutions, the demand for acupuncture devices is expected to rise significantly in the coming years.

By Application

Neuropathic Pain:

Neuropathic pain, resulting from nerve damage or dysfunction, is one of the most challenging pain types to manage. Devices aimed specifically at alleviating neuropathic pain, such as neurostimulation devices and electrical stimulation units, are crucial for patient care. The growing prevalence of conditions leading to neuropathic pain, including diabetes and multiple sclerosis, is driving the demand for effective pain management solutions in this segment. With advancements in technology allowing for better targeting and modulation of pain signals, the effectiveness of neuropathic pain treatment is expected to improve significantly. Thus, the need for specialized devices in managing neuropathic pain presents a substantial opportunity in the pain management devices market.

Musculoskeletal Pain:

Musculoskeletal pain, encompassing a broad range of conditions affecting muscles, bones, and joints, is prevalent among various age groups, particularly older adults. Devices such as electrical stimulation units, radiofrequency ablation devices, and analgesic infusion pumps are commonly used in managing musculoskeletal pain effectively. The rising incidence of conditions like osteoarthritis and sports-related injuries has increased the demand for innovative pain management solutions. Furthermore, as awareness regarding the importance of physical rehabilitation and pain management grows, the market for devices addressing musculoskeletal pain is anticipated to expand. The integration of technology in these devices, enabling better monitoring and personalization of treatment, is set to enhance patient outcomes in managing musculoskeletal pain.

Cancer Pain:

Cancer pain management is a critical aspect of oncology care, with pain levels varying significantly among patients. Advanced pain management devices such as analgesic infusion pumps and neurostimulation devices play a crucial role in providing relief to cancer patients. The increasing global cancer incidence drives the demand for effective pain management solutions tailored to individual patient needs. Additionally, with advancements in cancer treatments, the need for effective pain control becomes even more prominent. The development of innovative devices combined with comprehensive pain management strategies is expected to enhance the quality of life for cancer patients, thereby positively impacting this segment of the market.

Facial Pain:

Facial pain, often resulting from conditions such as trigeminal neuralgia and temporomandibular joint disorders, requires specialized pain management strategies. Devices like neurostimulation devices and transcutaneous electrical nerve stimulation units are increasingly utilized for alleviating facial pain. The rising awareness about effective pain management solutions for facial pain disorders is propelling the growth of this segment. As treatments become more personalized, the preference for devices that provide targeted relief for facial pain is likely to increase. Innovative technologies, including bioelectronic devices that can modulate nerve activity, contribute to the effectiveness of managing facial pain, thereby enhancing market growth.

Migraine:

Migraine is a prevalent neurological disorder characterized by recurrent headaches that can significantly impact daily life. The demand for devices specifically targeting migraine relief, such as wearable neurostimulation devices and headache relief patches, is on the rise. As awareness regarding non-pharmacological treatment options grows, many patients seek alternatives to traditional migraine medications. Innovative pain management devices that offer a combination of efficacy and convenience are increasingly favored. The growing incidence of migraine among individuals, coupled with advancements in device technology, is expected to further drive the demand for effective migraine pain management solutions in the upcoming years.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics are primary distribution channels for pain management devices, as they provide a comprehensive range of services. Patients often seek specialized care in these settings, facilitating the adoption of advanced pain management technologies. The integration of pain management devices in treatment protocols led by healthcare professionals contributes to improved patient outcomes. Additionally, hospitals are increasingly investing in cutting-edge technologies to enhance their service offerings and meet growing patient demands. As the emphasis on pain management in clinical settings continues to rise, the market for pain management devices through hospitals and clinics is anticipated to witness significant growth.

Online Stores:

Online stores have become a significant distribution channel for pain management devices, providing patients with convenient access to various products. As e-commerce continues to expand, more patients are opting to purchase pain management devices online due to the ease of access and the ability to compare products and prices. The rise of telehealth services has further propelled this trend, allowing patients to consult with healthcare providers regarding device selection before making a purchase. The convenience of home delivery and a wide range of offerings contribute to the growing popularity of purchasing pain management devices through online channels. As consumer behavior shifts towards online shopping, this segment is expected to grow substantially.

Retail Pharmacies:

Retail pharmacies are essential distribution points for over-the-counter pain management devices, catering to patients seeking immediate relief options. Many individuals prefer to purchase pain management devices locally for quick access and hands-on consultation. The growing availability of pain management products in retail pharmacies is driven by increasing consumer awareness and demand for self-care solutions. Additionally, pharmacies often play a crucial role in educating patients about the correct usage of these devices, thereby enhancing user experience and satisfaction. As retail pharmacies continue to stock a variety of pain management devices, this distribution channel is expected to see steady growth, catering to all segments of the population.

Others:

The 'Others' category encompasses various alternative distribution channels, including specialty stores and direct-to-consumer sales through manufacturers. Specialty stores often provide a curated selection of pain management devices, catering to specific needs and preferences of customers. Direct-to-consumer sales enable manufacturers to build strong relationships with patients, allowing for personalized marketing strategies and tailored product offerings. The growth of alternative distribution channels is driven by consumer demand for diverse options and the need for specialized pain management solutions. As companies explore innovative ways to reach consumers directly, the 'Others' segment is expected to contribute significantly to the overall growth of the pain management devices market.

By Technology

Electric Stimulation:

Electric stimulation technology is widely used in pain management devices, primarily focusing on interrupting pain signals transmitted to the brain. Devices such as TENS units and neurostimulation devices utilize electrical impulses to alleviate pain effectively. The growing acceptance of non-invasive pain management solutions is driving the demand for electric stimulation technologies. Furthermore, continuous advancements in this field, including the development of complex algorithms that customize stimulation parameters, are enhancing device efficacy. As more patients seek alternatives to traditional pain relief methods, electric stimulation technologies are expected to remain a prominent choice in the pain management devices market.

Ultrasound:

Ultrasound technology is increasingly being integrated into pain management devices for its ability to provide targeted pain relief through deep tissue penetration. Therapeutic ultrasound devices can promote tissue healing, reduce inflammation, and alleviate pain, making them popular among healthcare providers. The growing trend towards minimally invasive procedures enhances the adoption of ultrasound-based pain management technologies. Additionally, advancements in ultrasound technology, such as portable and user-friendly devices, are facilitating their use in homecare settings, making pain management accessible to a broader audience. Overall, the integration of ultrasound technology in pain management devices is expected to contribute significantly to market growth.

Radiofrequency:

Radiofrequency technology is essential for pain management devices, particularly those designed for targeted nerve ablation and modulation. Radiofrequency ablation devices provide effective pain relief by disrupting nerve signals responsible for pain perception. The increasing prevalence of chronic pain conditions, coupled with the demand for minimally invasive treatments, drives the adoption of radiofrequency technologies. Furthermore, ongoing research and development aimed at improving the precision and efficiency of radiofrequency procedures are enhancing their appeal among healthcare professionals. As more patients seek effective pain management solutions, the radiofrequency technology segment is anticipated to thrive in the market.

Spinal Cord Stimulation:

Spinal cord stimulation (SCS) technology is a vital aspect of pain management devices, particularly for patients with chronic pain syndromes. SCS devices deliver electrical impulses to the spinal cord, altering the perception of pain and providing significant relief for patients. The growing body of evidence supporting the efficacy of SCS in managing chronic pain is fostering increased adoption among healthcare practitioners. Additionally, advancements in SCS technology, including wireless devices and rechargeable batteries, enhance patient convenience and satisfaction. As the understanding of chronic pain mechanisms evolves, the demand for spinal cord stimulation technologies is expected to rise, significantly impacting the pain management devices market.

Analgesic Infusion:

Analgesic infusion technology is pivotal in delivering precise doses of pain relief medications to patients experiencing acute or chronic pain. Infusion pumps ensure consistent and controlled delivery of analgesics, improving patient comfort and satisfaction. The rising demand for personalized pain management solutions, particularly in post-surgical and oncology settings, is driving the adoption of analgesic infusion devices. With innovations in infusion technology, such as the integration of smart pumps equipped with remote monitoring capabilities, these devices are becoming increasingly efficient. The expanding applications of analgesic infusion technology in various healthcare environments are expected to bolster growth in this segment of the market.

By Region

The pain management devices market is witnessing significant growth across various regions, with North America leading in market share. In 2022, North America accounted for approximately 40% of the global market, driven by the high prevalence of chronic pain conditions and a well-established healthcare infrastructure. The increasing investments in healthcare technologies and the growing number of pain management specialists in the region are further bolstering market growth. Moreover, advancements in pain management technologies, along with the rising adoption of telehealth services, are expected to sustain the growth momentum in North America, projected to grow at a CAGR of around 11.4% from 2025 to 2035.

Europe is another key region in the pain management devices market, holding approximately 30% market share in 2022. The increasing awareness regarding chronic pain management and the rising adoption of innovative pain relief devices are driving growth in this region. The growing geriatric population, coupled with the rising prevalence of musculoskeletal disorders, is further expected to enhance market demand. Additionally, the strong presence of established healthcare players in countries like Germany, France, and the UK contributes to the market's expansion. The Asia Pacific region is projected to exhibit the fastest growth, with a CAGR of around 12.2% from 2025 to 2035, attributed to the increasing healthcare spending and the rising incidence of chronic pain conditions.

Opportunities

The pain management devices market is poised for substantial growth, presenting numerous opportunities for manufacturers and healthcare providers. One of the significant opportunities lies in the increasing focus on personalized pain management solutions, where devices can be tailored to meet individual patient needs. As patients become more informed about their treatment options, they are seeking devices that offer customization and effective pain relief. Moreover, the integration of digital health technologies, such as mobile applications and telehealth services, is opening new avenues for pain management. These technologies facilitate better patient monitoring and engagement, ultimately leading to improved outcomes and patient satisfaction.

Additionally, ongoing research and development in the field of pain management are driving innovation and the introduction of advanced devices. Collaborations between healthcare providers and technology companies are producing cutting-edge solutions that enhance pain management efficacy. Moreover, the increasing prevalence of chronic pain conditions globally suggests a continuous demand for effective pain management devices. As healthcare systems around the world prioritize pain management, there is a significant opportunity for market players to invest in developing advanced technologies that improve patient care and overall treatment experiences.

Threats

While the pain management devices market presents numerous growth opportunities, it is also faced with certain threats that could hinder its progress. One of the primary concerns is the stringent regulatory environment governing medical devices, which can delay the approval process for new products. Manufacturers must navigate complex regulatory frameworks, which can result in increased costs and prolonged time to market. Additionally, the emergence of alternative therapies, including natural and holistic approaches, poses competitive pressure on pain management devices. Patients may opt for these alternatives, potentially impacting the adoption of traditional pain management solutions.

Furthermore, the ongoing challenges related to reimbursement policies for pain management devices can hinder market growth. Many healthcare insurance providers have limited coverage for advanced pain management treatments, making it difficult for patients to afford these devices. This situation can lead to reduced accessibility and adoption among patients, ultimately affecting market expansion. The economic factors, including fluctuations in healthcare expenditure and budget constraints faced by hospitals and clinics, could also influence the purchasing decisions concerning pain management devices.

Competitor Outlook

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• PainTEQ
• Halyard Health, Inc.
• NeuroMetrix, Inc.
• Axonics Modulation Technologies
• Promedon
• Zynex Medical, Inc.
• Cleveland Medical Devices, Inc.
• Stimwave Technologies
• Alphatec Spine, Inc.
• InWave Technologies
• Huntleigh Healthcare

The competitive landscape of the pain management devices market is characterized by the presence of several prominent players, each striving to enhance their market position through innovation and strategic partnerships. Companies like Medtronic and Boston Scientific Corporation are at the forefront, offering a diverse range of advanced pain management solutions. These companies continually invest in research and development to introduce innovative technologies that address emerging pain management needs. The emphasis on patient-centric approaches and the integration of digital health solutions are key strategies being adopted by leading players in the market.

Abbott Laboratories and Stryker Corporation are also significant competitors in the pain management devices sector. Abbott is recognized for its advanced neurostimulation devices and infusion systems, while Stryker focuses on minimally invasive surgical techniques for pain management. Both companies have established strong distribution networks and are actively involved in expanding their product portfolios to cater to the growing demand for effective pain relief solutions. Additionally, their strategic collaborations with healthcare providers enhance their market reach and improve patient access to innovative pain management technologies.

Emerging companies like Axonics Modulation Technologies and Stimwave Technologies are gaining traction in the market with their novel approaches to pain management. Axonics has made significant advancements in rechargeable neurostimulation devices, promoting user convenience and satisfaction. Similarly, Stimwave Technologies focuses on wireless neurostimulation solutions, which are garnering interest among healthcare practitioners and patients alike. As these companies continue to innovate and challenge established players, the competitive dynamics of the pain management devices market are expected to evolve.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 PainTEQ
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Promedon
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 NeuroMetrix, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 InWave Technologies
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Stryker Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Zynex Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Alphatec Spine, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Halyard Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Huntleigh Healthcare
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Stimwave Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Axonics Modulation Technologies
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cleveland Medical Devices, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pain Management Devices Market, By Technology
    • 6.1.1 Electric Stimulation
    • 6.1.2 Ultrasound
    • 6.1.3 Radiofrequency
    • 6.1.4 Spinal Cord Stimulation
    • 6.1.5 Analgesic Infusion
  • 6.2 Pain Management Devices Market, By Application
    • 6.2.1 Neuropathic Pain
    • 6.2.2 Musculoskeletal Pain
    • 6.2.3 Cancer Pain
    • 6.2.4 Facial Pain
    • 6.2.5 Migraine
  • 6.3 Pain Management Devices Market, By Product Type
    • 6.3.1 Electrical Stimulation Devices
    • 6.3.2 Radiofrequency Ablation Devices
    • 6.3.3 Analgesic Infusion Pumps
    • 6.3.4 Neurostimulation Devices
    • 6.3.5 Acupuncture Devices
  • 6.4 Pain Management Devices Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Online Stores
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pain Management Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pain Management Devices market is categorized based on

By Product Type

• Electrical Stimulation Devices
• Radiofrequency Ablation Devices
• Analgesic Infusion Pumps
• Neurostimulation Devices
• Acupuncture Devices

By Application

• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial Pain
• Migraine

By Distribution Channel

• Hospitals & Clinics
• Online Stores
• Retail Pharmacies
• Others

By Technology

• Electric Stimulation
• Ultrasound
• Radiofrequency
• Spinal Cord Stimulation
• Analgesic Infusion

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• PainTEQ
• Halyard Health, Inc.
• NeuroMetrix, Inc.
• Axonics Modulation Technologies
• Promedon
• Zynex Medical, Inc.
• Cleveland Medical Devices, Inc.
• Stimwave Technologies
• Alphatec Spine, Inc.
• InWave Technologies
• Huntleigh Healthcare